Healios K.K. (TYO:4593)
Japan · Delayed Price · Currency is JPY 449.00
+29.00 (6.90%)
At close: Mar 6, 2026
Healios K.K. Market Cap
Healios K.K. has a market cap or net worth of 60.62 billion as of March 6, 2026. Its market cap has increased by 132.48% in one year.
Market Cap
60.62B
Enterprise Value
57.56B
Revenue
104.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
449.00
Market Cap Chart
Since June 16, 2015, Healios K.K.'s market cap has decreased from 67.08B to 60.62B, a decrease of -9.63%. That is a compound annual growth rate of -0.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 60.62B | 91.62% |
| Dec 30, 2025 | 31.63B | 98.29% |
| Dec 30, 2024 | 15.95B | 29.70% |
| Dec 29, 2023 | 12.30B | -25.62% |
| Dec 30, 2022 | 16.54B | -76.63% |
| Dec 30, 2021 | 70.75B | -30.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 165.62B |
| SanBio Company | 152.24B |
| Takara Bio | 138.00B |
| Oncolys BioPharma | 75.97B |
| Nxera Pharma | 75.02B |
| Cuorips | 56.45B |
| Japan Tissue Engineering | 28.14B |
| Renascience | 23.85B |